Investing.com - Burberry (LON:BRBY) shares slumped Monday after the British luxury giant issued a profit warning following a disappointing first quarter, resulting in it replacing its CEO and suspending its dividend. At 06:05 ET (10:05 GMT), Burberry stock fell over 16% to £7.37, down almost 50% so far this year. The group said that if the recent trading slowdown continues, it expects to report an operating loss for the first half of this year and full-year operating profit below current consensus. Additionally, the luxury house said its FY25 dividend payment will be suspended, although the final FY24 proposed dividend will still be paid in August. It also named Joshua Schulman, who formerly led Michael Kors and Coach, as new CEO with Jonathan Akeroyd stepping down “with immediate effect by mutual agreement with the Board.” “We are operating against a backdrop of slowing luxury demand with all key regions impacted by macroeconomic uncertainty and contributing to the sector slowdown,” Burberry said. The company has been battling with dwindling luxury appetite across its major markets, with a cost-of-living crisis affecting its European and U.S. customers, and economic concerns plaguing Asian consumers. “Today's warning by Burberry follows the sharp Swatch Group (SIX:UHR) miss and will add further concerns for luxury investors as the reporting season gets underway,” said analysts at Jefferies, in a note. “The scale of the sequential sales slowdown seen in calendar Q2 is certainly greater than expected. The lack of a reprieve so far in July suggests softening comps are just not sufficient enough to provide a turn in the trend.” Unlike Swatch, Burberry's release does not identify the Chinese cluster as the only source of weakness, suggesting in turn that there may be more deep-rooted brand specific challenges at play, Jefferies added. Jefferies maintained a ‘hold’ rating, with a £10.00 price target. Related Articles Burberry slumps after profit warning, change of CEO US stock futures rise as markets digest Trump attack, await Powell's speech Cleveland-Cliffs to buy Stelco in a $2.5 billion cash-and-stock deal, shares down
Burberry slumps after profit warning, change of CEO
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...